The present work demonstrated the mesenchymal stem cell-like properties of CD133+ glioblastoma-initiating cells by examining the pluripotency, stemness characteristics and differentiation potential of CD133+ glioblastoma cells. The gene discussed is PROM1; the disease is glioblastoma.